Abstract:The mechanism of neuronal loss in Alzheimer's disease (AD) remains unknown, although circumstantial evidence of apoptosis in postmortem brain tissues has supported the hypothesis that an apoptotic mechanism plays a role in the neurodegeneration in AD. Mutations in presenilins 1 and 2 (PS1/2) are responsible for the majority of familial AD. These proteins are localized predominantly in the endoplasmic reticulum (ER) and Golgi apparatus, and form heteromeric protein complexes to participate in several functions. Previous studies have shown that PS1/2 are involved in the regulation of apoptotic cell death, although the molecular basis is still unresolved. The aim of this study is to clarify the molecular basis by which PS1/2 regulate apoptosis. We also address a question how presenilin mutations modify the regulatory activity. We performed yeast 2–hybrid screen, co–immunoprecipitation assay, glycerol velocity gradient centrifugation and subcellular fractionation with iodixanol gradient, using HEK293 cells, PS1/2–knockout mouse fibroblasts and I213T–PS1–knockin mouse brains. PS1/2 interacted with FKBP38 that is an immunophilin family member residing in the mitochondrial membrane and inhibits apoptosis by targeting and anchoring anti–apoptotic Bcl–2 to the mitochondria. PS1/2 and FKBP38 formed macromolecular complexes together with Bcl–2. This complex formation promoted the degradation of FKBP38 and Bcl–2, and sequestered these proteins in the ER/Golgi compartments, thereby inhibiting FKBP38–mediated mitochondrial targeting of Bcl–2. Thus, full–length PS1/2 increased the susceptibility to apoptosis by antagonizing the anti–apoptotic function of FKBP38. In contrast, C–terminal fragments of caspase–processed PS1/2 redistributed Bcl–2 to the mitochondria by abrogating the activity of full–length PS1/2, resulting in a dominant–negative anti–apoptotic effect. In cultured cells and mutant PS1–knockin mouse brains, familial AD–linked PS1/2 mutants enhanced the pro–apoptotic activity by causing a more efficient reduction in mitochondrial Bcl–2 than wild–type PS1/2. We demonstrated that PS1/2 regulate the susceptibility to apoptosis by interacting with FKBP38. These results suggest a novel molecular mechanism for the regulation of mitochondria–mediated apoptosis by competition between PS1/2 and FKBP38 for subcellular targeting of Bcl–2. Furthermore, familial AD–linked mutations in PS1/2 could lower the threshold for activation of mitochondria–mediated apoptosis pathways in neurons of individuals with familial AD.

Presenilin-1, mutated in familial Alzheimer's disease, maintains genome stability via a γ-secretase dependent way

Mutation Analysis of Presenilin-1 Gene in Alzheimer' S Disease Patients and the Effects of Its Mutation on Expression of Presenilin-1 and Amyloid Precursor Protein

Genetic Dissection of Γ-Secretase-dependent And-Independent Functions of Presenilin in Regulating Neuronal Cell Cycle and Cell Death

A Presenilin-1 Mutation Identified in Familial Alzheimer Disease with Cotton Wool Plaques Causes a Nearly Complete Loss of Γ-Secretase Activity

Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: involvement of perturbed calcium homeostasis.

P4-196: Presenilin in Neuronal Survival and Neurodegeneration

Random Mutagenesis of Presenilin-1 Identifies Novel Mutants Exclusively Generating Long Amyloid β-Peptides

Presenilin-1 Knockin Mice Reveal Loss-of-Function Mechanism for Familial Alzheimer’s Disease

Pathological and Physiological Functions of Presenilins

PS1/gamma-secretase acts as rogue chaperone of glutamate transporter EAAT2/GLT-1 in Alzheimer's disease

Presenilin 1 Regulates Pharmacologically Distinct Gamma -Secretase Activities. Implications for the Role of Presenilin in Gamma -Secretase Cleavage.

Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Aβ42 and Aβ40 peptides by γ-secretase

Familial Alzheimer Disease-linked Presenilin 1 Variants Enhance Production of Both Aβ1–40 and Aβ1–42 Peptides That Are Only Partially Sensitive to a Potent Aspartyl Protease Transition State Inhibitor of “Γ-Secretase”

P3-402: Pathogenic Mutations of Presenilins Enhance Pro-Apoptotic Activity by Reducing Mitochondrial Bcl-2

Substitution of a Glycogen Synthase Kinase-3β Phosphorylation Site in Presenilin 1 Separates Presenilin Function from β-Catenin Signaling*

PS1 Affects the Pathology of Alzheimer’s Disease by Regulating BACE1 Distribution in the ER and BACE1 Maturation in the Golgi Apparatus

Presenilin Deficiency Results in Cellular Cholesterol Accumulation by Impairment of Protein Glycosylation and NPC1 Function

Repression of transcription of presenilin-1 inhibits γ-secretase independent ER Ca²⁺ leak that is impaired by FAD mutations

A role for presenilin 1 in regulating the delivery of amyloid precursor protein to the cell surface.

Presenilin-1 Regulates Intracellular Trafficking and Cell Surface Delivery of β-Amyloid Precursor Protein

Cortical Neurodegeneration Caused by Psen1 Mutations is Independent of Aβ.